Notably, Mukhopadhyay et al. showed recently, that in a mesenchymal-like breast cancer cell line (MDA-MB-231), which expresses robust levels of endogenous LKB1 (in contrast to the majority of breast cancer metastases), activated PLD induces a reduction in phospho-AMPK59. This evidence concerns the gene GPLD1 and breast carcinoma.